Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marci L Chew

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Serum anticholinergic activity and cognition in patients with moderate-to-severe dementiaMarci L Chew, Benoit H Mulsant, Bruce G Pollock
Current Psychiatry Reports|February 14, 2008
Pharmacokinetics in geriatric psychiatryKristin L Bigos, Marci L Chew, Robert R Bies
Pharmaceutical Research|April 14, 2016
Minimization of CYP2D6 Polymorphic Differences and Improved Bioavailability via Transdermal Administration: Latrepirdine ExampleMarci L Chew, Joyce Mordenti, Thean Yeoh, et al.
Pain|June 8, 2014
A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathyDavid M Simpson, Andrew S C Rice, Birol Emir, et al.
Epilepsia|November 8, 2014
Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled studyDonald Mann, Jing Liu, Marci L Chew, et al.
Clinical Drug Investigation|August 1, 2014
Pregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studiesMarci L Chew, Christine W Alvey, Anna Plotka, et al.
The Clinical Journal of Pain|October 19, 2016
Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled TrialCynthia L Huffman, James N Goldenberg, James Weintraub, et al.
Clinical Drug Investigation|August 1, 2014
Pharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studiesMarci L Chew, Anna Plotka, Christine W Alvey, et al.
Clinical Drug Investigation|March 27, 2015
Effect of the gastrointestinal prokinetic agent erythromycin on the pharmacokinetics of pregabalin controlled-release in healthy individuals: a phase I, randomized crossover trialMarci L Chew, Anna Plotka, Christine W Alvey, et al.
Pediatric Rheumatology Online Journal|August 1, 2016
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension studyLesley M Arnold, Kenneth N Schikler, Lucinda Bateman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Serum anticholinergic activity and cognition in patients with moderate-to-severe dementiaMarci L Chew, Benoit H Mulsant, Bruce G Pollock
Current Psychiatry Reports|February 14, 2008
Pharmacokinetics in geriatric psychiatryKristin L Bigos, Marci L Chew, Robert R Bies
Pharmaceutical Research|April 14, 2016
Minimization of CYP2D6 Polymorphic Differences and Improved Bioavailability via Transdermal Administration: Latrepirdine ExampleMarci L Chew, Joyce Mordenti, Thean Yeoh, et al.
Pain|June 8, 2014
A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathyDavid M Simpson, Andrew S C Rice, Birol Emir, et al.
Epilepsia|November 8, 2014
Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: a phase 1, randomized controlled studyDonald Mann, Jing Liu, Marci L Chew, et al.
Clinical Drug Investigation|August 1, 2014
Pregabalin controlled-release pharmacokinetics in healthy volunteers: analysis of four multiple-dose randomized clinical pharmacology studiesMarci L Chew, Christine W Alvey, Anna Plotka, et al.
The Clinical Journal of Pain|October 19, 2016
Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia: A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled TrialCynthia L Huffman, James N Goldenberg, James Weintraub, et al.
Clinical Drug Investigation|August 1, 2014
Pharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studiesMarci L Chew, Anna Plotka, Christine W Alvey, et al.
Clinical Drug Investigation|March 27, 2015
Effect of the gastrointestinal prokinetic agent erythromycin on the pharmacokinetics of pregabalin controlled-release in healthy individuals: a phase I, randomized crossover trialMarci L Chew, Anna Plotka, Christine W Alvey, et al.
Pediatric Rheumatology Online Journal|August 1, 2016
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension studyLesley M Arnold, Kenneth N Schikler, Lucinda Bateman, et al.
Pageof 2